Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Uric acid nephrolithiasis, Urolithiasis, Elevated fractional excretion of urate, and Acute kidney injury and others; and common findings: Protein in the urine (proteinuria), Oliguria, and Elevated creatinine (kidney function marker) (elevated circulating creatinine concentration).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 6 | Uric acid nephrolithiasis, Protein in the urine (proteinuria), Acute kidney injury |
SLC22A12 function has not been fully characterized.
Hypouricemia, renal 1 is associated with mutations in the SLC22A12 gene on chromosome 11.
Genetic testing for SLC22A12 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 8 always present features, 3 common features.
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions and drug therapy. Pipeline includes 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
12 publications have been identified in PubMed for hypouricemia, renal 1. Research spans Case Report / Case Series (50%), Basic Science / Preclinical (25%), and Other (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 50% |
Data assembled from 6 of 12 sources · Last updated Sep 17, 2026, 10:46 PM UTC
Online Mendelian Inheritance in Man
Lab test results | 1 | Elevated creatinine (kidney function marker) (elevated circulating creatinine concentration) |
Laboratory research | 3 | 25% |
Other research | 1 | 8% |
Research summaries | 1 | 8% |
Disease patterns and progression | 1 | 8% |
Pezantes I (2026). [PMID: 41496734](https://pubmed.ncbi.nlm.nih.gov/41496734/). *Nephrology (Carlton)*. [Case Report / Case Series]
Yamamoto S (2026). [PMID: 41759742](https://pubmed.ncbi.nlm.nih.gov/41759742/). *J Biol Chem*. [Basic Science / Preclinical]
Mymrikov EV (2026). [PMID: 41453723](https://pubmed.ncbi.nlm.nih.gov/41453723/). *J Mol Biol*. [Basic Science / Preclinical]
Sugihara S (2025). [PMID: 39361182](https://pubmed.ncbi.nlm.nih.gov/39361182/). *Clin Exp Nephrol*. [Epidemiology / Natural History]
Cui Y (2025). [PMID: 41327034](https://pubmed.ncbi.nlm.nih.gov/41327034/). *BMC Nephrol*. [Case Report / Case Series]
Venyte R (2025). [PMID: 40810925](https://pubmed.ncbi.nlm.nih.gov/40810925/). *Z Rheumatol*. [Review / Meta-Analysis]
Matsushita D (2025). [PMID: 40186864](https://pubmed.ncbi.nlm.nih.gov/40186864/). *Cell Rep*. [Basic Science / Preclinical]
Sulaiman S (2024). [PMID: 38899214](https://pubmed.ncbi.nlm.nih.gov/38899214/). *Kidney Int Rep*. [Case Report / Case Series]
Paladugu NR (2024). [PMID: 39421323](https://pubmed.ncbi.nlm.nih.gov/39421323/). *Front Nephrol*. [Case Report / Case Series]
Gao Y (2024). [PMID: 39107999](https://pubmed.ncbi.nlm.nih.gov/39107999/). *Ren Fail*. [Case Report / Case Series]